Sign in

CIK 0001563880

  • Non-accelerated filer
  • Smaller reporting company

Trevi Therapeutics, Inc.

Sign in to watch
Ticker
TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450834299
Phone
+1 203-304-2499
Business address
195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$595,806
in 1 filing, $596K under 10b5-1 plans

Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Heffernan Michael Thomas −$596K Director sold 86% of stake

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-09 Mellon Family Investment Co V 10% owner Other acquisition +24,340 247,156
2019-05-09 Mellon Family Investment Co V 10% owner Purchase +100,000 $10.00 $1.0M 347,156
2019-05-09 Mellon Family Investment Co V 10% owner Conversion · Series C Preferred Stock −1,908,450 0
2019-05-09 OSHEA WILLIAM J 10% owner Conversion +99,046 114,080
2019-05-09 OSHEA WILLIAM J 10% owner Conversion · Series A Preferred Stock −307,607 0
2019-05-09 OSHEA WILLIAM J 10% owner Conversion · Series C Preferred Stock −478,951 0
2019-05-09 Heffernan Michael Thomas Director Conversion +3,851 3,851
2019-05-09 Heffernan Michael Thomas Director Purchase +2,500 $10.00 $25K 6,351
2019-05-09 Heffernan Michael Thomas Director Conversion · Series C Preferred Stock −34,247 0
2019-05-09 GOOD JENNIFER L Conversion +18,348 194,954
2019-05-09 GOOD JENNIFER L Purchase +11,250 $10.00 $113K 206,204
2019-05-09 GOOD JENNIFER L Conversion · Series A Preferred Stock −109,015 0
2019-05-09 GOOD JENNIFER L Conversion · Series C Preferred Stock −23,947 0
2019-05-09 Aperture Venture Partners IV, L.P. 10% owner Conversion +232,963 232,963
2019-05-09 Aperture Venture Partners IV, L.P. 10% owner Purchase +112,000 $10.00 $1.1M 344,963
2019-05-09 Aperture Venture Partners IV, L.P. 10% owner Conversion · Series C Preferred Stock −2,054,795 0
2019-05-09 Agger Mette Kirstine Director Conversion +776,544 776,544
2019-05-09 Agger Mette Kirstine Director Purchase +375,000 $10.00 $3.8M 1,151,544
2019-05-09 Agger Mette Kirstine Director Conversion · Series C Preferred Stock −6,849,315 0
2019-05-09 Richard King Mellon Foundation 10% owner Conversion +222,816 222,816

Page 20 of 21 · 419 trades